Fecal miR‐223 is a noninvasive biomarker for estimating Crohn's disease activity

MLA

Juanjuan Zhang, et al. “Fecal MiR‐223 Is a Noninvasive Biomarker for Estimating Crohn’s Disease Activity.” Immunity, Inflammation and Disease, vol. 11, no. 12, Dec. 2023. EBSCOhost, https://doi.org/10.1002/iid3.1131.

APA

Juanjuan Zhang, Zhen Guo, Zhiming Wang, Weiming Zhu, & Qiurong Li. (2023). Fecal miR‐223 is a noninvasive biomarker for estimating Crohn’s disease activity. Immunity, Inflammation and Disease, 11(12). https://doi.org/10.1002/iid3.1131

Chicago

Juanjuan Zhang, Zhen Guo, Zhiming Wang, Weiming Zhu, and Qiurong Li. 2023. “Fecal MiR‐223 Is a Noninvasive Biomarker for Estimating Crohn’s Disease Activity.” Immunity, Inflammation and Disease 11 (12). doi:10.1002/iid3.1131.